27 Dec, 13:29 - Indian

SENSEX 78775.46 (0.39)

Nifty 50 23845.650390625 (0.40)

Nifty Bank 51304 (0.26)

Nifty IT 43781.6484375 (0.27)

Nifty Midcap 100 57091.44921875 (-0.06)

Nifty Next 50 68887.1015625 (-0.40)

Nifty Pharma 23027.44921875 (1.39)

Nifty Smallcap 100 18763.44921875 (0.19)

27 Dec, 13:29 - Global

NIKKEI 225 40281.16 (1.80)

HANG SENG 20090.47 (-0.04)

S&P 6084.5 (-0.37)

Cancel

BSE Code : 500124 | NSE Symbol : DRREDDY | ISIN : INE089A01031 | Industry : Pharmaceuticals |

(27-Dec-24 13:05) Dr Reddys Laboratories Ltd soars 2.41%, Gains for third straight session
(24-Dec-24 11:16) DRL arm incorporates new WOS to expand operations in Finland
(24-Dec-24 10:51) Dr Reddys Laboratories to convene board meeting
(20-Dec-24 13:05) Dr Reddys Laboratories Ltd gains for third straight session
(20-Dec-24 09:31) Dr Reddys Laboratories allots 13,080 equity shares under ESOS
(28-Nov-24 10:11) Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India
(28-Nov-24 09:14) Dr Reddys launches immuno-oncology drug - Toripalimab in India
(21-Nov-24 10:23) DRL slips after Hyderabad facility gets 7 observations from USFDA
(20-Nov-24 10:40) DRL’s Hyderabad facility gets 7 observations from USFDA
(14-Nov-24 09:22) Mexican health regulator imposes penalty on Dr Reddy's

1 2 3 4 5 6 7 8 9 10

Dr Reddys Laboratories Ltd